US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NYSE
Horizon Technology Finance Corporation (HTFA) 銘柄情報

Horizon Technology Finance Corporation (HTFA)

25.15

0.00

(0.00%)

終了 7月12日 5:00AM

0.00

0.00

(0.00%)

取引時間後: -

Horizon Technology Finance Corporation (HTFA) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

25.15

( - )

買値

-

売値

-

出来高

-

平均取引量 (3 か月)

US$ 911,284

財務取引量

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

企業価値

729.409M

前日終値

25.15

始値

-

時刻

最終取引時間

VWAP

-

歳入

95.58M

純利益

21.55M

発行済株式数

68,261,111

浮動株比率 (%)

-

機関投資家保有比率 (%)

4.72%

配当利回り

1.27 (17.65%)

PER

9.5

株価売上高倍率 (PSR)

3.31

1 株当たり利益 (EPS)

0.49

ベータ

0.96

Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare infor... Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, cleantech and sustainability industries. It seeks to invest in companies in the United States. 詳細を表示

セクター

-

業界

-

本社

Farmington, United States

設立

2026

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

HTFA - Frequently Asked Questions (FAQ)

What is the current Horizon Technology Finance Corporation share price?

The current share price of Horizon Technology Finance Corporation is US$ 25.15

How many Horizon Technology Finance Corporation shares are in issue?

Horizon Technology Finance Corporation has 68,261,111 shares in issue

What is the market cap of Horizon Technology Finance Corporation?

The market capitalisation of Horizon Technology Finance Corporation is USD 1.72B

What is the 1 year trading range for Horizon Technology Finance Corporation share price?

Horizon Technology Finance Corporation has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Horizon Technology Finance Corporation?

The price to earnings ratio of Horizon Technology Finance Corporation is 9.5

What is the cash to sales ratio of Horizon Technology Finance Corporation?

The cash to sales ratio of Horizon Technology Finance Corporation is 3.31

What is the registered address of Horizon Technology Finance Corporation?

The registered address for Horizon Technology Finance Corporation is 312 Farmington Avenue, Farmington, Connecticut, 06032

sharkey1

sharkey1 2分前

And so does Kirko.

wadegarret

wadegarret 3分前

Best year 2009 up 580%- This year up 290% so far

That is, in my real portfolio. Sometimes Wadegarret portfolio performs better, and sometime worse, as I do more trading in my real portfolio. Gernerally speaking I play the same stocks, but sometimes I do a lot more trading in my

Nightdaytrader

Nightdaytrader 4分前

They better do it before October elections because if Dems win, nothing will happen and then in January, 2027, I think Maxine Waters will take over House Banking Committee that oversees FDIC.

Baxers

If they had disclosed then the other side would have had a runaway field day on the information and the stock price would be even further in bits and raising capital would be even more difficult that it already is. Entirely unsurprised that (if my idea is correct) they didn't disclose. Caught betwee

Goats'nCrows

Goats'nCrows 6分前

LC, I have been paying attention, and I have been reading your stances. I mean no offense or attack but I can no more believe that you are spending Saturday to selflessly convince shareholders to save themselves/the company than I can believe the "Cofer is under your bed" crowd.

Ar

learningcurve2020

learningcurve2020 8分前

So what’s Advent doing with 85 employees and about $30M in revenues back in 2024? Plus they have the business and Cognate / River to hold their hand. My belief is they already pivoted as you can see by Advent’s website.

Nemesis18

Nemesis18 13分前

I didn't feel that I needed to answer, but
if the MHRA or FDA issues a definitive rejection or demands a completely new Phase III trial, due to the trial's controversial external-control design, NWBO's valuation will face an existential threat.
Without DCVax-L approval, they would b

kenjiroo

kenjiroo 13分前

I hope I can still spin my head at old age !! Cant wait forever 😜

learningcurve2020

learningcurve2020 14分前

If you were at all paying attention my stance has always been to get off your sheepish butts before it’s too late to 1) force new management 2) claw back Advent 3) get the CDMO up and running! Somehow 2 was achieved but sneakily without the revenues, sadly.

Steady_T

Steady_T 14分前

Wouldn't ADVENT be a wholly owned subsidiary?

CryptoRain

CryptoRain 15分前

Yes it does but those holding through the Jan 5 ex date and then sold will most likely get it too. This company is doing things right

kspar1

kspar1 15分前

https://www.patreon.com/posts/163510848

Impressions on The CHMP Blarcamesine Rejection Justification"

Upbeat re-visit of the CHMP conclusion by Bio_Oko. Basically, he observes that Anavex was trying to get those folks to see the goodness in the numbers, hoping they'd i

Lime Time

Lime Time 16分前

Yeah forgot about this one. Bigtime scam in the past. They used to advertise on iHub. Really good share structure. Will check it out. They put it in the time capsule in 2023. Someone gotta open it up some day

boston745

boston745 16分前

Another example where current management, but not current board, kept Sintx undervalued was back in February of 2025. This attempt to keep Sintx undervalued likely had multiple reasons behind it but that list definitely includes keeping Sintx undervalued for the offering in February and likely again

boston745

boston745 17分前

Another example where current management, but not current board, kept Sintx undervalued was back in February of 2025. This attempt to keep Sintx undervalued likely had multiple reasons behind it but that list definitely includes keeping Sintx undervalued for the offering in February and likely again

Jetmek_03052

Jetmek_03052 17分前

As usual, you are wrong.

I never said I was an "expert" on DBMM's financial reports. I said I had forecast DBMM's revenues pretty accurately. And my past posts about them have been proven to be just that.

Where did I say I was an "expert"? Sounds like your opinion a

Steady_T

Steady_T 18分前

$.17 is proof that the drug has not been approved in 923 days.

The jury i.e. MHRA is still out on whether the drug works or not.

Any other conclusion is based on wishful thinking.

Bizreader

Bizreader 18分前

Yep and let's see what happens going forward giving the current state of affairs. Maybe a pendulum or whiplash experience may be next up giving patterns of history.

larrybaz

larrybaz 18分前

Thanks for all the hard work, SSKILLZ. Should be an interesting contest. I'll be interested to see how the indices fare. We will find out if our collective stock-picking ability paints us as contenders or pretenders!

02opida

02opida 18分前

Recent Trades -
Time ET Ex Price Change Volume
15:36:59 Q 0.0071 0.0008 200,000
15:30:40 Q 0.0071 0.0008 13,579
14:49:32 Q 0.00704 0.00074 25,000
14:49:32 Q 0.007 0.0007 25,000
14:49:32 Q 0.00704 0.00074 25,000
14:49:32 Q 0.007 0.0007 25,000
1

randomwalk007

randomwalk007 19分前

The reason it’s taken so long is BIOAQ had to wait until CERN was shut down to close off the parallel universe and enable the completion of the merger. Duh!

radly

Is this going lower or is it time to buy?

02opida

02opida 20分前

70 out here at the foot of the mountain

Goats'nCrows

Goats'nCrows 21分前

Company is broke.

And I think I can fairly assume you would be willing to add that we longs are about to languish in more silence...waiting on certain death.

So why all the effort if we're really about to get our comeuppance as a result of the ill behavior you attrib

Horizon Technology Finance

Fidelity Advisor Growth ...

Anglo American (QX)

Lincoln Inflation Plus F...

Capital Group Internatio...

Adams Diversified Equity

Ml Bank Sinopac

Amundi MSCI Europe Scree...

Action Televerbier

American Salars Lithium

Alliance Global (PK)

Etfs Gasoline Micro

ABN AMRO Bank NV

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。